The development of generic versions of Onivyde® (irinotecan liposome injection) requires a reliable and discriminative in vitro release test (IVRT) to ensure product quality and support regulatory approval. Conventional dialysis-based IVRT often is limited in maintaining sink conditions and is affected by membrane-related variability and batch inconsistency. To overcome these challenges, we developed an IVRT using Bio-Beads SM...